Relationship between mental impairment and HPA axis activity in dementia disorders. 1994

J Balldin, and K Blennow, and G Bråne, and C G Gottfries, and I Karlsson, and B Regland, and A Wallin
University of Göteborg, Department of Clinical Neuroscience, Mölndal Hospital, Sweden.

In 40 patients with Alzheimer's disease (AD, < 65 years), 56 patients with senile dementia of the Alzheimer type (SDAT, > or = 65 years) and 45 patients with vascular dementia (VAD), basal cortisol levels were estimated and the dexamethasone test (DST) was performed. The degree of dementia was assessed according to DSM-III-R and the GBS scale was used for quantitative measures of functional impairment. There were no significant differences in basal cortisol levels. Especially in the VAD group, scores on functional impairment correlated significantly with post-DST cortisol levels. The results indicate hypothalamic overactivity in demented patients which can be correlated to the degree of dementia. In VAD, and to a certain extent also in SDAT, there appears to be a disconnection between cortical areas, including the hippocampus and the hypothalamus.

UI MeSH Term Description Entries
D007030 Hypothalamo-Hypophyseal System A collection of NEURONS, tracts of NERVE FIBERS, endocrine tissue, and blood vessels in the HYPOTHALAMUS and the PITUITARY GLAND. This hypothalamo-hypophyseal portal circulation provides the mechanism for hypothalamic neuroendocrine (HYPOTHALAMIC HORMONES) regulation of pituitary function and the release of various PITUITARY HORMONES into the systemic circulation to maintain HOMEOSTASIS. Hypothalamic Hypophyseal System,Hypothalamo-Pituitary-Adrenal Axis,Hypophyseal Portal System,Hypothalamic-Pituitary Unit,Hypothalamic Hypophyseal Systems,Hypothalamic Pituitary Unit,Hypothalamo Hypophyseal System,Hypothalamo Pituitary Adrenal Axis,Portal System, Hypophyseal
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010913 Pituitary-Adrenal System The interactions between the anterior pituitary and adrenal glands, in which corticotropin (ACTH) stimulates the adrenal cortex and adrenal cortical hormones suppress the production of corticotropin by the anterior pituitary. Pituitary Adrenal System,Pituitary-Adrenal Systems,System, Pituitary-Adrenal,Systems, Pituitary-Adrenal
D003704 Dementia An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness. Senile Paranoid Dementia,Amentia,Familial Dementia,Amentias,Dementia, Familial,Dementias,Dementias, Familial,Dementias, Senile Paranoid,Familial Dementias,Paranoid Dementia, Senile,Paranoid Dementias, Senile,Senile Paranoid Dementias
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J Balldin, and K Blennow, and G Bråne, and C G Gottfries, and I Karlsson, and B Regland, and A Wallin
January 1990, Progress in neuro-psychopharmacology & biological psychiatry,
J Balldin, and K Blennow, and G Bråne, and C G Gottfries, and I Karlsson, and B Regland, and A Wallin
January 1989, Progress in clinical and biological research,
J Balldin, and K Blennow, and G Bråne, and C G Gottfries, and I Karlsson, and B Regland, and A Wallin
May 2010, Journal of neural transmission (Vienna, Austria : 1996),
J Balldin, and K Blennow, and G Bråne, and C G Gottfries, and I Karlsson, and B Regland, and A Wallin
November 2002, Psychopharmacology,
J Balldin, and K Blennow, and G Bråne, and C G Gottfries, and I Karlsson, and B Regland, and A Wallin
July 2014, World journal of clinical cases,
J Balldin, and K Blennow, and G Bråne, and C G Gottfries, and I Karlsson, and B Regland, and A Wallin
May 2016, Biological psychology,
J Balldin, and K Blennow, and G Bråne, and C G Gottfries, and I Karlsson, and B Regland, and A Wallin
May 2005, The Journal of clinical endocrinology and metabolism,
J Balldin, and K Blennow, and G Bråne, and C G Gottfries, and I Karlsson, and B Regland, and A Wallin
September 2009, European child & adolescent psychiatry,
J Balldin, and K Blennow, and G Bråne, and C G Gottfries, and I Karlsson, and B Regland, and A Wallin
December 2011, CNS neuroscience & therapeutics,
J Balldin, and K Blennow, and G Bråne, and C G Gottfries, and I Karlsson, and B Regland, and A Wallin
January 2002, Psychoneuroendocrinology,
Copied contents to your clipboard!